Hudson Bay Capital Management LP Reata Pharmaceuticals Inc Transaction History

Hudson Bay Capital Management LP

  • $21.9 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$79.22 - $105.37 $3.17 Million - $4.21 Million
40,000 New
40,000 $4.08 Million
Q4 2022

Feb 14, 2023
BUY
$22.15 - $42.11 $443,000 - $842,200
20,000 New
20,000 $759,000
Q2 2021

Aug 16, 2021
SELL
$78.27 - $151.29 $485,665 - $938,754
-6,205 Closed
0 $0
Q1 2021

May 14, 2021
BUY
$94.25 - $132.81 $584,821 - $824,086
6,205 New
6,205 $619,000

Others Institutions Holding RETA

# of Institutions
5
Shares Held
62.7K
Call Options Held
0
Put Options Held
0
View Full List

About REATA PHARMACEUTICALS INC

RETA Quotes by TradingView
  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track Hudson Bay Capital Management LP Portfolio

Follow Hudson Bay Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Hudson Bay Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email